Lifevantage Corporation (NASDAQ:LFVN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $5.73 and traded as high as $6.84. Lifevantage shares last traded at $6.8280, with a volume of 68,409 shares trading hands.
Analyst Ratings Changes
LFVN has been the topic of a number of research reports. Lake Street Capital lowered Lifevantage from a "buy" rating to a "hold" rating and set a $5.00 price objective on the stock. in a report on Thursday, May 7th. Weiss Ratings raised shares of Lifevantage from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $5.00.
Read Our Latest Stock Analysis on LFVN
Lifevantage Stock Up 3.8%
The stock has a market cap of $86.17 million, a PE ratio of 15.17 and a beta of 0.72. The business has a 50 day moving average price of $7.02 and a 200 day moving average price of $5.73.
Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The company had revenue of $43.72 million for the quarter, compared to analysts' expectations of $47.77 million. On average, research analysts predict that Lifevantage Corporation will post 0.6 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in shares of Lifevantage by 870.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company's stock valued at $66,000 after buying an additional 4,499 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Lifevantage during the 2nd quarter worth $76,000. BNP Paribas Financial Markets grew its holdings in shares of Lifevantage by 2,555.8% during the second quarter. BNP Paribas Financial Markets now owns 6,135 shares of the company's stock worth $80,000 after buying an additional 5,904 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of Lifevantage during the first quarter worth $97,000. Finally, New York State Common Retirement Fund acquired a new stake in shares of Lifevantage in the second quarter valued at about $102,000. Institutional investors and hedge funds own 35.32% of the company's stock.
About Lifevantage
(
Get Free Report)
LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.
Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
